Literature DB >> 15087703

Pernicious anemia associated with interferon-alpha therapy and chronic hepatitis C infection.

Emmanuel Andrès, Noureddine Henoun Loukili, Maher Ben Abdelghani, Esther Noel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15087703     DOI： 10.1097/00004836-200404000-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  4 in total

1.  Pernicious anemia in case of chronic viral hepatitis infection: Pernicious anemia and chronic viral hepatitis.

Authors:  Emmanuel Andres; Mustapha Mecili; Ecaterina Ciobanu
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

2.  Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study.

Authors:  Jui-Ming Liu; Ren-Jun Hsu; Fung-Wei Chang; Feng-Hsiang Chiu; Chia-Lun Yeh; Chun-Fa Huang; Shu-Ting Chang; Hung-Chang Lee; Hsin Chi; Chien-Yu Lin
Journal:  Ther Clin Risk Manag       Date:  2017-09-13       Impact factor: 2.423

3.  Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Authors:  Iram Gull; Muhammad Shahbaz Aslam; Imran Tipu; Roohi Mushtaq; Tehseen Zamir Ali; Muhammad Amin Athar
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 4.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.